Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
• 1.4 Market by Type
  • 1.4.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Exosomes and RNA
  • 1.4.3 CTCs and ctDNA
• 1.5 Market by Application
  • 1.5.1 Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Physicians'office Laboratories
  • 1.5.4 Clinical Diagnostic Laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Lung Cancer Liquid Biops Market Perspective (2015-2026)
• 2.2 Global Lung Cancer Liquid Biops Growth Trends by Regions
  • 2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Lung Cancer Liquid Biops Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Lung Cancer Liquid Biops Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Lung Cancer Liquid Biops Players by Market Size
  • 3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2015-2020)
  • 3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Lung Cancer Liquid Biops Market Concentration Ratio
  • 3.2.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2019
• 3.3 Lung Cancer Liquid Biops Key Players Head office and Area Served
• 3.4 Key Players Lung Cancer Liquid Biops Product Solution and Service
• 3.5 Date of Enter into Lung Cancer Liquid Biops Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2015-2020)
• 4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Lung Cancer Liquid Biops Market Size by Application (2015-2020)
• 5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lung Cancer Liquid Biops Market Size (2015-2020)
• 6.2 Lung Cancer Liquid Biops Key Players in North America (2019-2020)
• 6.3 North America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 6.4 North America Lung Cancer Liquid Biops Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Lung Cancer Liquid Biops Market Size (2015-2020)
• 7.2 Lung Cancer Liquid Biops Key Players in Europe (2019-2020)
• 7.3 Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 7.4 Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020)

8 China

• 8.1 China Lung Cancer Liquid Biops Market Size (2015-2020)
• 8.2 Lung Cancer Liquid Biops Key Players in China (2019-2020)
• 8.3 China Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 8.4 China Lung Cancer Liquid Biops Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Lung Cancer Liquid Biops Market Size (2015-2020)
• 9.2 Lung Cancer Liquid Biops Key Players in Japan (2019-2020)
• 9.3 Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 9.4 Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2015-2020)
• 10.2 Lung Cancer Liquid Biops Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 10.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020)

11 India

• 11.1 India Lung Cancer Liquid Biops Market Size (2015-2020)
• 11.2 Lung Cancer Liquid Biops Key Players in India (2019-2020)
• 11.3 India Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 11.4 India Lung Cancer Liquid Biops Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Lung Cancer Liquid Biops Market Size (2015-2020)
• 12.2 Lung Cancer Liquid Biops Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
• 12.4 Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Biocept
  • 13.1.1 Biocept Company Details
  • 13.1.2 Biocept Business Overview
  • 13.1.3 Biocept Lung Cancer Liquid Biops Introduction
  • 13.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020))
  • 13.1.5 Biocept Recent Development
• 13.2 EntroGen
  • 13.2.1 EntroGen Company Details
  • 13.2.2 EntroGen Business Overview
  • 13.2.3 EntroGen Lung Cancer Liquid Biops Introduction
  • 13.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.2.5 EntroGen Recent Development
• 13.3 Cynvenio Biosystems
  • 13.3.1 Cynvenio Biosystems Company Details
  • 13.3.2 Cynvenio Biosystems Business Overview
  • 13.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
  • 13.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.3.5 Cynvenio Biosystems Recent Development
• 13.4 Exosome Diagnostics
  • 13.4.1 Exosome Diagnostics Company Details
  • 13.4.2 Exosome Diagnostics Business Overview
  • 13.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
  • 13.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.4.5 Exosome Diagnostics Recent Development
• 13.5 F. Hoffmann-La Roche
  • 13.5.1 F. Hoffmann-La Roche Company Details
  • 13.5.2 F. Hoffmann-La Roche Business Overview
  • 13.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
  • 13.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.5.5 F. Hoffmann-La Roche Recent Development
• 13.6 Clearbridge BioMedics
  • 13.6.1 Clearbridge BioMedics Company Details
  • 13.6.2 Clearbridge BioMedics Business Overview
  • 13.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
  • 13.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.6.5 Clearbridge BioMedics Recent Development
• 13.7 Bio-Rad Laboratories
  • 13.7.1 Bio-Rad Laboratories Company Details
  • 13.7.2 Bio-Rad Laboratories Business Overview
  • 13.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
  • 13.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.7.5 Bio-Rad Laboratories Recent Development
• 13.8 Agena Bioscience
  • 13.8.1 Agena Bioscience Company Details
  • 13.8.2 Agena Bioscience Business Overview
  • 13.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
  • 13.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.8.5 Agena Bioscience Recent Development
• 13.9 Cancer Genetics
  • 13.9.1 Cancer Genetics Company Details
  • 13.9.2 Cancer Genetics Business Overview
  • 13.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
  • 13.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.9.5 Cancer Genetics Recent Development
• 13.10 CellMax Life
  • 13.10.1 CellMax Life Company Details
  • 13.10.2 CellMax Life Business Overview
  • 13.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
  • 13.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 13.10.5 CellMax Life Recent Development
• 13.11 Nateras
  • 10.11.1 Nateras Company Details
  • 10.11.2 Nateras Business Overview
  • 10.11.3 Nateras Lung Cancer Liquid Biops Introduction
  • 10.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.11.5 Nateras Recent Development
• 13.12 MedGenome
  • 10.12.1 MedGenome Company Details
  • 10.12.2 MedGenome Business Overview
  • 10.12.3 MedGenome Lung Cancer Liquid Biops Introduction
  • 10.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.12.5 MedGenome Recent Development
• 13.13 OncoDNA
  • 10.13.1 OncoDNA Company Details
  • 10.13.2 OncoDNA Business Overview
  • 10.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
  • 10.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.13.5 OncoDNA Recent Development
• 13.14 Genomic Health
  • 10.14.1 Genomic Health Company Details
  • 10.14.2 Genomic Health Business Overview
  • 10.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
  • 10.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.14.5 Genomic Health Recent Development
• 13.15 Trovagene
  • 10.15.1 Trovagene Company Details
  • 10.15.2 Trovagene Business Overview
  • 10.15.3 Trovagene Lung Cancer Liquid Biops Introduction
  • 10.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.15.5 Trovagene Recent Development
• 13.16 Fluxion Biosciences
  • 10.16.1 Fluxion Biosciences Company Details
  • 10.16.2 Fluxion Biosciences Business Overview
  • 10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
  • 10.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.16.5 Fluxion Biosciences Recent Development
• 13.17 Biodesix
  • 10.17.1 Biodesix Company Details
  • 10.17.2 Biodesix Business Overview
  • 10.17.3 Biodesix Lung Cancer Liquid Biops Introduction
  • 10.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.17.5 Biodesix Recent Development
• 13.18 Epic Sciences
  • 10.18.1 Epic Sciences Company Details
  • 10.18.2 Epic Sciences Business Overview
  • 10.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
  • 10.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.18.5 Epic Sciences Recent Development
• 13.19 Shuwen Biotech
  • 10.19.1 Shuwen Biotech Company Details
  • 10.19.2 Shuwen Biotech Business Overview
  • 10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
  • 10.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.19.5 Shuwen Biotech Recent Development
• 13.20 Personal Genome Diagnostics
  • 10.20.1 Personal Genome Diagnostics Company Details
  • 10.20.2 Personal Genome Diagnostics Business Overview
  • 10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
  • 10.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.20.5 Personal Genome Diagnostics Recent Development
• 13.21 Predicine
  • 10.21.1 Predicine Company Details
  • 10.21.2 Predicine Business Overview
  • 10.21.3 Predicine Lung Cancer Liquid Biops Introduction
  • 10.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020)
  • 10.21.5 Predicine Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer